Menu
Lee VK, Lee T, Ghosh A, Saha T, Bais MV, Bharani KK, Chag M, Parikh K, Bhatt P, Namgung B,…
Read More
Kumar A, Agrawal A, Bharani KK, Mavely L. Evaluation of Hemostatic Effectiveness in a Standard Swine Hemorrhage Model of Severe…
Read More
Ketan P, Anjali P, Rignesh P, Bhavika P, Priyank P, Dev P. Assessing the efficacy of haemostatic dressing Axiostat® in…
Read More
Kabeer M, Venugopalan PP, Subhash VC. Pre-hospital hemorrhagic control effectiveness of Axiostat® dressing versus conventional method in acute hemorrhage due…
Read More
Minici, R., Serra, R., Maglia, C., Guzzardi, G., Spinetta, M., Fontana, F., Venturini, M. and Laganà, D., 2023. Efficacy and…
Read More
Perri, P., Curcio, F., De Luca, M., Piro, P., Trombino, S. and Cassano, R., 2025. Evaluation of Chitosan-Based Axiostat as…
Read More
A HN, Kumar A, Agrawal A, Mavely L, Bhatia D. Characterization of a Bioactive Chitosan Dressing: A Comprehensive Solution for…
Read More
East, W.M., Evaluation of a Bioactive Microfiber Gelling Technology (BMG)® dressing in the management of chronic wounds: a case series. Journal…
Read More
Pramod, S., 2023. Management of malignant fungating wounds with a Bioactive Microfiber Gelling Technology (BMG)® dressing: an evaluation.
Read More
Tickle, J., 2023. Evaluation of a chitosan dressing in the management of hard-to-heal wounds. British Journal of Nursing, 32(4), pp.S44-S50.
Read More
Kulkarni, M., Deshpande, S. and Lokapure, S., 2022. Use of chitosan-based dressings for the management of a chronic lower limb…
Read More
Nair, H.K., 2022. Evaluation of a novel chitosan wound healing dressing based on Bioactive Microfiber Gelling Technology (BMG)®: A case series.…
Read More
Jansy Williams, Managing Complex Post-Surgical Abdominal Wound Dehiscence in a Young Patient: A Case Study, E-Poster, Wounds UK Conference, 2025.
Read More
Bethany Nightingale, Managing Complex Category 4 Pressure Ulcers in Spinal Cord Injury: A Case Study Using MaxioCel, E-Poster, Wounds UK Conference,…
Read More
Louise Scannell, Paediatric Burn Wound Management: Clinical Outcomes from a Case Series Using MaxioCel Chitosan Dressings, E-Poster, Wounds UK Conference, 2025.
Read More
Like many sectors tissue viability services have been affected by and had to learn lessons from the COVID-19 pandemic. The pandemic has…
Read More
Tissue Viability is an area of healthcare that has synergy with many medical specialties and care settings. Our team covers…
Read More
Ulceration of the lower limbs results in painful, often debilitating leg wounds that can have a profound effect on patients…
Read More
730,000 adults (1.5% of the adult population of the UK) have a leg ulcer in one year. As a major vascular…
Read More
A recent study revealed that 55.2% of respondents provided care to patients with malignant fungating wounds (MFW) in community settings.…
Read More
Wounds to the face and head can pose unique challenges, often impacting patient confidence and quality of life (QoL). This…
Read More
Self-care is the ability of individuals to care for themselves, allowing them to take an active role to achieve, maintain or optimise their…
Read More
Affecting approximately 3.8 million people in the UK, chronic wounds can heavily impact a person’s life. Patients with a wound…
Read More
Cancer diagnosis and subsequent treatments induce a set of symptoms and problems specific to each individual experiencing the disease trajectory.
Read More
Smith, P. and Bagley, S. (2024) Bioactive Microfiber Gelling Technology (BMG)® to support patient self-care: A case study. EWMA Conference 2024,…
Read More
Gilbert K., A Twenty-Patient Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers, E-Poster, Wounds UK…
Read More
Di-Romana, E. (2024) Severe pressure ulcer debridement in the acute sector: Case study series to support a change in clinical…
Read More
Parker, J., Sweeney, R. & Burr, S. (n.d.) A multi-disciplinary team approach to the management of squamous cell carcinoma wounds…
Read More
Cancela, C., Afonso, G., Cunha, C.A.C., Mimoso, M., Macedo, S., Amorim, A.P.R.D.M., and Soares Dias, P.A.C.B. (2024) Evaluating a chitosan…
Read More
Alves, A.R. and Marques, M.S. (2024) A case study on the effectiveness of a chitosan lactate microfibre dressing in managing…
Read More
Cernica, C.W., 2023. EP020 ACCELERATING THE CHRONIC WOUND HEALING PROCESS WITH A TREATMENT COMBINATION OF 100% CHITOSAN WOUND DRESSING AND…
Read More
Pramod, S. (2022) A ten-patient case study series of the impact of a 100% chitosan-based dressing with Bioactive Microfiber Gelling Technology…
Read More© Advamedica Inc 2025. All Rights Reserved
Accomplished Medical Sales Professional with a 20 year record of growing markets, increasing product penetration and leading high performance sales teams in hemostat business. Previously Phil was Vice President at Core Scientific and spent a decade at ZMedica, a leading hemostat company as Regional Sales Director. Phil has a business management degree from Florida State University.
Dr. Mahadevan is a Professor of Emergency Medicine at Stanford University where he has been a recipient of numerous teaching awards. He also serves as the Director of Global Affairs and Strategy for Stanford Medicine. He received his medical degree from David Geffen School of Medicine at UCLA.
Dr. Sengupta serves as the Associate Professor of Medicine at HMS and as the Associate Professor of Health Sciences and Technology at MIT. Dr. Sengupta received his PhD from University of Cambridge as a British Chevening and Nehru Scholar, and is a recipient of the TR35 Innovator Award from the MIT Technology Review Magazine and the Era of Hope Scholar Award from the US Department of Defense.
Satish brings a wealth of diverse experiences to his CFO role at Advamedica. In addition to his Fortune 500 roles (FedEx, Citi, AmEx, JPM Chase) in various leadership capacities across multiple countries, he has worked with a number of startups and SMBs as their in-house or consulting CFO. Over the last three years, Satish has helped companies raise over $100 million in venture capital and financing.
Quality professional with over 25 years of experience in the medical device, pharmaceutical, and software industries.
Maria is specialized in developing and implementing Quality Management Systems and has deep knowledge and experience in audit preparation, resolution/remediation as per regulatory compliance in ISO 13485, 21 CFR Part 820, EU MDR, MDSAP, and other regional regulations (China, Taiwan, Brazil, Japan, Canada, Australia, Korea, Switzerland, etc.)
Samantha is Director of Clinical Marketing at Advamedica. Previously she was Global Training Manager in Terumo Aortic overseeing all training and clinical skills. Prior to that Samantha was National Sales & Marketing Manager in Bolton Medical, Italy for almost a decade. Samantha has done Executive MBA in Strategic Marketing and has Degree in Professional nursing from the University of Bologna, Italy.
Edward is US – National Sales Director at Advamedica. He comes with many decades of experience selling novel hemostats and woundcare products in over 26 states in the US. He was earlier Regional Sales Director at Z-Medica managing business of their Hemostatic product line for Surgery, Trauma, Cardiology, Burn and Wound Care. He is passionate about creating top performing teams, driven by diversity, inclusion, values and accountability. Edward has a Bachelor of Business Administration from Dowling College.
Oscar Rospigliosi is a Senior MedTech executive with broad experience in medical device sales and marketing. He was the CEO & Director at Scion Biomedical and prior to that, he was a CEO at Bolton Medical Group, guiding the company from $4.5mn in annual revenues to $80mn in the cardio-thoracic market.
Leo Mavely is the president of Advamedica Inc. He is passionate about medtech innovations for unmet healthcare needs, and has been featured by Fortune Magazine in 40 under 40 business leaders and by Entrepreneur Magazine in 35 under 35 Game-Changing Entrepreneurs. He holds a Bachelor’s degree in Bioengineering.
